TAŞKIRAN, B. Et Al. 2017. Neutrophil lymphocyte ratio in 6 month teriparatide therapy ofosteoporosis. 19th European congress of endocrinology , (Lizbon, Portugal).

TAŞKIRAN, B., Yorulmaz, G., Cansu, G. B., & AKALIN, A., (2017). Neutrophil lymphocyte ratio in 6 month teriparatide therapy ofosteoporosis . 19th European congress of endocrinology, Lizbon, Portugal

TAŞKIRAN, BENGÜR Et Al. "Neutrophil lymphocyte ratio in 6 month teriparatide therapy ofosteoporosis," 19th European congress of endocrinology, Lizbon, Portugal, 2017

TAŞKIRAN, BENGÜR Et Al. "Neutrophil lymphocyte ratio in 6 month teriparatide therapy ofosteoporosis." 19th European congress of endocrinology , Lizbon, Portugal, 2017

TAŞKIRAN, B. Et Al. (2017) . "Neutrophil lymphocyte ratio in 6 month teriparatide therapy ofosteoporosis." 19th European congress of endocrinology , Lizbon, Portugal.

@conferencepaper{conferencepaper, author={BENGÜR TAŞKIRAN Et Al. }, title={Neutrophil lymphocyte ratio in 6 month teriparatide therapy ofosteoporosis}, congress name={19th European congress of endocrinology}, city={Lizbon}, country={Portugal}, year={2017}}